Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint.

Area of Science:

• Obstetrics and Gynecology
• Biochemistry
• Pathology

Background:

• Pre-eclampsia (PE) is a significant cause of maternal and neonatal mortality, characterized by hypertension and proteinuria after 20 weeks of gestation.
• Current diagnostic and therapeutic strategies for PE remain limited, despite its long-recognized clinical significance.

Purpose of the Study:

• To investigate the role of toxic protein misfolding and aggregation as a critical etiological factor in pre-eclampsia.
• To explore the potential of targeting protein aggregation pathways for novel diagnostic and therapeutic interventions in PE.

Main Methods:

• Comparative proteomic analysis of serum samples from pre-eclampsia patients and normal pregnancies.
• Identification and characterization of dysregulated proteins, focusing on transthyretin (TTR) and amyloid precursor protein.

Main Results:

• Several proteins were identified as dysregulated in pre-eclampsia sera.
• Evidence of transthyretin (TTR) aggregates detected in sera from PE patients.
• Amyloid precursor protein aggregates were found in the PE placenta.

Conclusions:

• Pre-eclampsia may be fundamentally a disease of protein misfolding and aggregation.
• This novel concept links PE pathogenesis to mechanisms observed in neurodegenerative diseases like Alzheimer's disease.
• Further research into aggregated proteins could lead to new diagnostic and therapeutic approaches for pre-eclampsia.